Where to buy CJC-1295.

You can buy CJC-1295 from research-supply vendors online. That's the only route: it isn't approved anywhere, and it sits on the FDA's list of substances pharmacies may not compound. Two different molecules are sold under the name, so the vendor question matters more here than almost anywhere else.

CJC-1295

Referenced in this guide

Batch-matched COAHPLC + mass specResearch use only

The CJC-1295 referenced throughout this article, supplied as a research compound with a certificate of analysis matched to the lot you receive — the check this site argues you should hold any supplier to.

Shop CJC-1295

Where can you buy CJC-1295?

CJC-1295 has exactly one open buying channel: research-supply vendors online, selling it as a research reference compound with no prescription. The retail-pharmacy and compounding routes are both closed, and the reasons are worth knowing.

• Research-supply vendor: The only route. Lyophilized powder, meaning freeze-dried, under Research Use Only labeling. No prescription.
• Compounding pharmacy: Closed. CJC-1295 sits on the FDA's bulks-not-eligible-for-503A lists, so a pharmacy can't prepare it for human use.
• Retail pharmacy on prescription: Closed. Clinical development halted around 2007 and there's no current sponsor, so no approved product exists.

We'd read that middle row as the important one. A compound named on the FDA's not-eligible list has been looked at and set aside, which is a different position from simply never being reviewed.

Six vendors, all checked on 13 August 2026 against what each will show you before you pay: a third-party certificate you can open, and whether the testing lab is named in the vendor's own copy or only inside the PDF. We did not verify CJC-1295 prices, so there is no price column here — pricing across these same vendors is benchmarked on BPC-157 in our full vendor comparison, where the spread runs $6.30–$12.45 per mg. Stock varies by compound, so check each catalogue for CJC-1295.

Three caveats travel with that table. Peptriva and Red Rock sell 10 mg vials only, so their per-milligram figures in the BPC-157 benchmark are not comparable with a 5 mg row. Swiss Chems sells its BPC-157 as the arginine salt rather than the plain peptide, so it is not a like-for-like product. And Red Rock publishes no certificate of analysis at all, despite advertising verified COAs. Where To Buy Peptides earns a commission on purchases made through its links, Peptriva included — see our disclosure.

The identity check specific to CJC-1295: CAS 863288-34-0 is the no-DAC registration, and because the name alone settles nothing, make the vendor state which variant the vial holds — DAC, with a 6–8 day half-life, or no-DAC at roughly 30 minutes.

What is CJC-1295, and why are there two of them?

CJC-1295 is a synthetic copy of the first 29 amino acids of human growth-hormone-releasing hormone, the brain signal that triggers GH pulses. ConjuChem developed it in the early 2000s as a once-weekly drug candidate, as Rahman and colleagues recount.

It activates the GH pathway in the pituitary. It doesn't bind the ghrelin pathway, which is ipamorelin's job. That's why researchers stack the two rather than choose one.

The thing that decides which CJC-1295 you have is the DAC group. DAC stands for Drug Affinity Complex, a small chemical linker that bonds to albumin in blood.

Albumin acts like a slow-release shuttle. Once the peptide is bound to it, the kidneys can't filter it out fast, as Memdouh and colleagues describe.

• No-DAC, also sold as Modified GRF 1-29: 29 amino acids, half-life about 30 minutes, produces natural GH pulses.
• DAC: 30 amino acids plus the linker, half-life 6–8 days, produces sustained GH elevation.

What should you check before buying CJC-1295?

Check four things on a CJC-1295 vial. The label must name DAC or no-DAC. The mass-spec figure must match that variant. The seller must make no clinical claims, and it must ship as powder rather than pre-mixed liquid. The general eight peptide-buyer criteria apply on top.

1. The label must say DAC or no-DAC

Naming the variant is the single most important CJC-1295 check. The vial and the CoA both have to tell you which one you bought. No-DAC has CAS number 863288-34-0, and DAC has a separate CAS registration.

A vendor selling “CJC-1295” without disambiguating is failing the most basic identity disclosure. Walk away.

2. The discontinuation history matters

ConjuChem halted CJC-1295 DAC clinical development around 2007. Public reporting attributes the decision in part to broader scrutiny of ConjuChem's DAC pipeline, after a fatal adverse event in a separate trial of CJC-1131, a different DAC-modified peptide.

We found no sign the program was ever revived, and CJC-1295 has no current pharmaceutical sponsor. A vendor making clinical claims about treating GH deficiency or reversing aging is in FDA enforcement territory.

3. Mass-spec must match the variant

For no-DAC, the theoretical mass is 3367.9 g/mol. The formula is C₁₅₂H₂₅₂N₄₄O₄₂.

Peptides this big usually show up in mass-spec as multi-charge ions: observed [M+2H]²⁺ near 1684.9, or [M+3H]³⁺ near 1123.6. The calculated neutral mass should land at 3367.9 within standard tolerance.

The DAC variant has a different molecular weight because the linker adds mass. A CoA reporting 3367.9 for a vial labeled DAC is internally inconsistent. Don't buy from that vendor.

4. Storage and shipping are unforgiving

CJC-1295 ships lyophilized and stores at −20°C long-term. Once you reconstitute it, the no-DAC form has a usable window of about 30 days refrigerated at 2–8°C. That's shorter than BPC-157, because CJC-1295 degrades faster in solution.

Vendors who sell pre-mixed liquid at room temperature are selling a product with a shelf life measured in days. The powder is what ships reliably.

What does CJC-1295 cost in 2026?

CJC-1295 costs $50–$100 for a 5 mg no-DAC vial and $80–$150 for the same size in DAC. It sits mid-curve for research peptides: longer than the 15-residue BPC-157, shorter than 44-residue tesamorelin. The DAC linker adds synthesis cost. Third-party tested retail in 2026:

• No-DAC, 5 mg vial: $50–$100, or $10–$20 per mg. Standard retail size.
• No-DAC, 10 mg vial: $80–$150, or $8–$15 per mg. Better per-mg value.
• DAC, 5 mg vial: $80–$150, or $16–$30 per mg. The conjugation step adds complexity.
• DAC, 10 mg vial: $130–$220, or $13–$22 per mg. Less commonly stocked.
• Multi-vial tiers: 10–25% off for 3- or 6-pack orders.

Below $40 per 5 mg no-DAC, or below $60 per 5 mg DAC, deserves a question. Each coupling step in a 29-amino-acid peptide is a chance for incomplete reaction. That means more impurities at the cheap end, where purification gets shortcut.

Is CJC-1295 legal to buy?

Yes. CJC-1295 is legal to buy as a research reference compound. It isn't FDA-approved, never finished clinical development, and lives on the FDA's bulks-not-eligible-for-503A-compounding lists. That closes the compounding channel for human use. It doesn't affect research sales.

Three more things the legal status does:

• It tells you about the evidence base. No active pharmaceutical sponsor means no ongoing trials. Recent PubMed literature from 2020 to 2026 is dominated by anti-doping detection methods.
• It closes the compounding pharmacy channel. Pharmacies can’t prepare CJC-1295 for human use.
• It triggers WADA prohibition under Category S2. Validated LC-MS/MS methods detect CJC-1295 at sub-ng/mL in urine, per Memdouh and Coppieters. Athletes are reliably detectable for no-DAC within hours and DAC for days.

Research-use sales operate under 21 CFR § 809.10(b)(9). Laboratory research stays legal. See peptides and the 2023 503A categorization for the deeper regulatory context.

What are the red flags when buying CJC-1295?

The biggest CJC-1295 red flag is a vial labeled only “CJC-1295” with no DAC status. Seven warning signs we’d skip:

• “CJC-1295” without DAC/no-DAC on the label. The single most basic identity disclosure.
• “CJC-1295 Pro,” “Long-Acting,” or branded variant names. The two real molecules are no-DAC and DAC. Anything else without a published structure is marketing.
• Pre-mixed liquid at room temperature. Shelf life in days, not weeks.
• Clinical claims on the product page. “Treats GH deficiency” or “reverses aging” are FDA enforcement territory for a discontinued-program compound.
• Missing CAS number. The no-DAC registration 863288-34-0 should resolve in PubChem in 30 seconds.
• Mass-spec result that doesn’t match the variant. No-DAC = 3367.9, or [M+2H]²⁺ near 1684.9.
• Vendor’s in-house QC instead of third-party testing. Independent ISO 17025 verification is the third-party tested standard.

CJC-1295 (no DAC)

10 mg ≥99% pure Lyophilized

Modified GRF 1-29, CAS 863288-34-0, MW 3367.9 g/mol. The same reference compound used across the 2020–2024 anti-doping detection literature and grouped in the 2026 Sports Medicine review of unapproved peptide therapies. COA with HPLC trace and mass-spec ships with every order.

Learn more

Frequently asked questions

Can a pharmacy sell you CJC-1295?

No. CJC-1295 has no approved product, so a retail pharmacy has nothing to dispense. Compounding pharmacies are blocked separately: the compound sits on the FDA's bulks-not-eligible-for-503A lists. Research-supply vendors selling under Research Use Only labeling are the only route.

Is CJC-1295 legal to buy?

Yes, as a research reference compound. CJC-1295 isn't FDA-approved, never finished clinical development, and sits on the FDA's bulks-not-eligible-for-503A list. That closes compounding pharmacies. It doesn't close research sales. CJC-1295 is also on the WADA Prohibited List under S2.

DAC or no-DAC, which CJC-1295 should you buy?

They're two different molecules. DAC adds an albumin-binding linker that stretches the half-life to 6–8 days. No-DAC, sold as Modified GRF 1-29, has a 30-minute half-life. Most current research use is the no-DAC form, because it preserves pulsatile GH release. If a listing says only “CJC-1295,” ask before you buy.

How much does CJC-1295 cost?

No-DAC CJC-1295 runs $50–$100 for 5 mg and $80–$150 for 10 mg. DAC runs $80–$150 for 5 mg and $130–$220 for 10 mg. The DAC variant costs more because linker conjugation adds synthesis complexity. Below those ranges, purity is the trade-off.

Why was CJC-1295 DAC discontinued?

ConjuChem halted CJC-1295 clinical development around 2007. Public reporting attributes the decision in part to scrutiny of the broader DAC pipeline, after a fatal adverse event in a separate trial of CJC-1131. The program never restarted, and CJC-1295 has no current sponsor.

How does CJC-1295 compare to ipamorelin?

CJC-1295 and ipamorelin act on different signaling pathways with complementary effects. CJC-1295 acts on the GH-releasing pathway. Ipamorelin acts on the ghrelin pathway and also blocks somatostatin, the brake on GH.

Researchers stack them because the two pathways combine well. A 2026 review reported the combination improved muscle force in mouse models of glucocorticoid-induced muscle loss, per Mayfield and colleagues. See the CJC-1295 vs Ipamorelin comparison.

What should a CJC-1295 CoA show?

For no-DAC CJC-1295: CAS 863288-34-0, HPLC purity above 98% with a chromatogram, and mass-spec at MW about 3367.9 g/mol. The mass usually shows as multi-charge ions [M+2H]²⁺ near 1684.9 or [M+3H]³⁺ near 1123.6.

Water content should be 2–8% by Karl Fischer titration, and counterion content is usually TFA at 5–15%. The DAC variant has a different MW because of the linker. The lab should be ISO 17025-accredited and named on the report.